Code: 21375024

Histiocytic Disorders

Name: Histiocytic Disorders
Brand: Springer International Publishing AG
SKU: 21375024
Price: 95.84 EUR
Availability: InStock

by Oussama Abla, Gritta Janka

Language: English
Binding: Paperback
Number of pages: 392
Publisher: Springer International Publishing AG, 2018
More about this

95.84 €

RRP: 100.64 €

You save 4.80 €

In stock at our supplier
Shipping in 6 - 8 days

Add to wishlist

Monster: The Perfect Edition, Vol. 5
18.56 € -18 %
Buy
JoJo's Bizarre Adventure: Part 3 - Stardust Crusaders, Vol. 7
17.65 € -16 %
Buy
Taking of Jake Livingston
16.64 € -6 %
Pre-order
Office: Talking Button
10.99 € -21 %
Buy
Stark wie wir
26.02 €
Buy
McGraw-Hill's Essential ESL Grammar
21.99 € -15 %
Buy
Tarot wskaże Ci drogę
9.88 € -29 %
Buy

Give this book as a present today

Order book and choose Gift Order.
We will send you book gift voucher at once. You can give it out to anyone.
Book will be send to donee, nothing more to care about.

Book gift voucher sample Read more

You get 240 loyalty points

Book synopsis

This volume provides a comprehensive and world-class review of the field of histiocytic neoplasms and hemophagocytic lymphohistiocytosis (HLH). It reviews all the advances in the field of histiocytoses during the last ten years, particularly with regards to the genomic findings in LCH and other histiocytic neoplasms and the new suggested classification of the histiocytic disorders. Additionally, it features a state-of-the art update on the most recent treatment strategies for LCH, including the results of the last LCH-III international trial, salvage therapies such as reduced-intensity conditioning (RIC) stem cell transplant (SCT), and targeted therapies with BRAF and MEK inhibitors, as well as the challenging cases of CNS-neurodegenerative LCH and its therapeutic perspectives. For primary and secondary HLH the book updates the most recent genetic and pathophysiological findings, including macrophage-activation syndrome (MAS), and includes a special chapter on HLH in adults. Treatment chapters encompass therapy for newly diagnosed HLH and refractory disease as well as stem-cell transplantation and novel therapies. The text also highlights the most recent advances in the treatment of the uncommon histiocytic disorders, such as Erdheim-Chester disease (ECD), Juvenile xanthogranuloma (JXG) and JXG-like conditions, Rosai-Dorfman disease (RDD), and the very rare malignant histiocytoses. Written by international experts in the field, Histiocytic Disorders is a valuable resource for clinicians, researchers, fellows and residents who are interested in or manage histiocytic disorders in children and adults.